SARAH DAWSON: Open Payments
NPI 1265030993 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 11 payments from 7 companies in 2025. Trend: 2023 $610 · 2024 $684 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $249 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $66 |
| Forte Bio-Pharma LLC | 2 | $36 |
| Medtronic, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| PharmaEssentia USA Corporation | 1 | $21 |
| DePuy Synthes Sales Inc. | 1 | $15 |
Products named: OPDIVO, REBLOZYL, JOURNAVX, PROLATE, PLASMABLADE(TM), VERZENIO, BESREMI, MONOVISC.
Industry payments across TX — which companies pay providers there.
